What does this research mean for the field?

Melatonin use by young children should be reduced or prevented due to the risks of unsupervised medication exposure and lack of evidence for efficacy in typically developing children. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

To assess the implications of melatonin use in young children and identify the need for reduced administration.

February 22, 2026

Literature review: Melatonin use by young children should be reduced or prevented

Key Points

To assess the implications of melatonin use in young children and identify the need for reduced administration.
Review of existing literature on melatonin prescriptions and outcomes in children aged 0 to 6.
Evaluation of the efficacy of melatonin in typically developing children versus those with autism.
Analysis of potential overdose incidents related to melatonin use.
Melatonin is frequently prescribed, yet its efficacy in typically developing children is not supported by evidence.
There is a significant risk of overdose due to unsupervised access to melatonin in young children.
Research on long-term outcomes of melatonin use beyond two years is lacking.

Abstract

Melatonin, increasingly prescribed as a sleep aid, is also a leading cause of unsupervised medication exposure and overdose among young children, ages 0 to 6 years. While there is evidence that it is a helpful sleep aid for young children with autism, there is no evidence of efficacy in typically developing children. In addition, there has been no research on outcomes beyond two years.

Bookmark

Literature review: Melatonin use by young children should be reduced or prevented

Key Points

Abstract

Cite This Study